Crescent Biopharma (CBIO) Shares Outstanding (2013 - 2026)

Crescent Biopharma (CBIO) has reported Shares Outstanding (Entity) for 14 consecutive years, with $27.8 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Shares Outstanding (Entity) rose 619.64% year-over-year to $27.8 million in Q2 2026; TTM through Jun 2026 was $27.8 million, a 619.64% increase from a year earlier, with the FY2025 full-year figure at $10.4 million, down 83.85% from the prior year.
• Shares Outstanding (Entity) was $27.8 million for Q2 2026 at Crescent Biopharma, up from $27.6 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $64.5 million in Q1 2025 and troughed at $3.9 million in Q2 2025.
• A 5-year average of $48.6 million and a median of $59.3 million in 2022 frame the typical range for Shares Outstanding (Entity).
• Across the five-year window, Shares Outstanding (Entity) plunged 94.02% in 2025 and surged 619.64% in 2026, its largest moves.
• Over 5 years, Shares Outstanding (Entity) stood at $54.4 million in 2022, then advanced by 18.42% to $64.4 million in 2023, then gained by 0.14% to $64.5 million in 2024, then slumped by 83.85% to $10.4 million in 2025, then surged by 166.54% to $27.8 million in 2026.
• The last three Shares Outstanding (Entity) figures came in at $27.8 million (Q2 2026), $27.6 million (Q1 2026), and $10.4 million (Q4 2025), per Business Quant data.